TherapeuticsMD, Inc. Financing Interest Expense
Discontinued › Expense Statement › Interest Expense
us-gaap:FinancingInterestExpense · last filed 2024-08-12
- TherapeuticsMD, Inc. financing interest expense for the quarter ending 2024-06-30 was $5.00K, a 88.89% decline year-over-year.
- TherapeuticsMD, Inc. financing interest expense for the quarter ending 2023-06-30 was $45.00K.
- TherapeuticsMD, Inc. financing interest expense for the quarter ending 2018-12-31 was $2.09M.
- TherapeuticsMD, Inc. financing interest expense for the quarter ending 2018-09-30 was $2.05M.
- TherapeuticsMD, Inc. financing interest expense for fiscal 2018 was $4.68M.
| Period end | Financing Interest Expense 3 month | Financing Interest Expense 6 month | Financing Interest Expense 9 month | Financing Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $5.00K 10-Q · filed 2024-08-12 | $5.00K 10-Q · filed 2024-08-12 | ||
| 2023-06-30 | $45.00K 10-Q · filed 2024-08-12 | $95.00K 10-Q · filed 2024-08-12 | ||
| 2018-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $4.15M derived: sum of 2 quarters · filed 2019-02-27 | $4.68M derived: sum of 3 quarters · filed 2019-02-27 | $4.68M 10-K · filed 2019-02-27 |
| 2018-09-30 | $2.05M 10-Q · filed 2018-11-08 | $2.58M derived: sum of 2 quarters · filed 2018-11-08 | $2.58M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $531.38K 10-Q · filed 2018-07-30 | $531.38K 10-Q · filed 2018-07-30 | ||
| 2018-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2019-02-27 |